Price History
Feb 9, 2026 — May 15, 2026Investment Snapshot
- Trading 67% below Graham Number ($0.83) — significant margin of safety
- Piotroski F-Score 2/9 — signs of financial weakness
- ROE of 5.3% — below-average profitability
- Revenue declining 13% annually
Synergy CHC Corp. - Common Stock (SNYR) is a Healthcare company operating in Medical Distribution, listed on the NASDAQ , with a market capitalisation of $4 million . Key value metrics: P/E ratio 1.0, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Synergy CHC Corp. - Common Stock — Fundamental Analysis Summary
Synergy CHC Corp. - Common Stock (SNYR) is trading 67% below its Graham Number of $0.83 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 1.0x.
On financial health, SNYR shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and modest return on equity of 5.3% (sector average: -20.6%).
StockPik's composite Value Score for SNYR is 50/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SNYR reports a high gross margin of 74.0% (sector average: 40.1%) and a solid operating margin of 14.4%.
SNYR shows revenue declining at 13% year-over-year, with earnings declining at 681%.